The DOI matches its OpenAlex record.
Prognostic significance of p53 mutations and 3p deletions in primary, resected non-small cell lung cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Vascular permeability factor (VPF, VEGF) in tumor biology
Senger, D. R., Van De Water, L., Brown, L. F., Nagy, J. A., Yeo, K.-T., Yeo, T.-K., Berse, B., Jackman, R. W., Dvorak, A. M., & Dvorak, H. F. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665960 · Cited by 840
_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0021 · Cited by 735
Ettinger, D. S., Akerley, W., Bepler, G., Blum, M. G., Chang, A., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Demmy, T. L., Ganti, A. K. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0056 · Cited by 730
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u · Cited by 673
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
Martin, M., Lefaix, J.-L., & Delanian, S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00435-1 · Cited by 657
Prognostic Factors in Non-small Cell Lung Cancer
Brundage, M. D., Davies, D., & Mackillop, W. J. (2002) · Chest · doi:10.1378/chest.122.3.1037 · Cited by 564
Human Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages
Sano, H., Hsu, D. K., Yu, L., Apgar, J. R., Kuwabara, I., Yamanaka, T., Hirashima, M., & Liu, F.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2156 · Cited by 521
Mechanism of Action of Camptothecin
Liu, L. F., Duann, P., Lin, C., D'Arpa, P., & Wu, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb26375.x · Cited by 508
Targeted Disruption of the Galectin-3 Gene Results in Attenuated Peritoneal Inflammatory Responses
Hsu, D. K., Yang, R.-Y., Pan, Z., Yu, L., Salomon, D. R., Fung-Leung, W.-P., & Liu, F.-T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64975-9 · Cited by 428
Steels, E., Paesmans, M., Berghmans, T., Branle, F., Lemaitre, F., Mascaux, C., Meert, A. P., Vallot, F., Lafitte, J. J., & Sculier, J. P. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00062201 · Cited by 418
Survival in early-stage non-small cell lung cancer
Nesbitt, J. C., Putnam, J. B., Walsh, G. L., Roth, J. A., & Mountain, C. F. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00169-l · Cited by 383
Clinical utility of cytokeratins as tumor markers
Barak, V., Goike, H., Panaretakis, K. W., & Einarsson, R. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.009 · Cited by 382
el Rouby, S., Thomas, A., Costin, D., Rosenberg, C., Potmesil, M., Silber, R., & Newcomb, E. (1993) · Blood · doi:10.1182/blood.v82.11.3452.3452 · Cited by 374
Association of p53 mutations with short survival in colorectal cancer
Hamelin, R., Laurent-Puig, P., Olschwang, S., Jego, N., Asselain, B., Remvikos, Y., Girodet, J., Salmon, R. J., & Thomas, G. (1994) · Gastroenterology · doi:10.1016/s0016-5085(94)94217-x · Cited by 345
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Diaz, T., Gel, B., Quera, A., Bandres, E., Garcia-Foncillas, J., Ramirez, J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp219 · Cited by 342
Oberhammer, F. A., Hochegger, K., Fröschl, G., Tiefenbacher, R., & Pavelka, M. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.4.827 · Cited by 341
Ahuja, V., Coleman, R. E., Herndon, J., & Patz, E. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980901)83:5<918::aid-cncr17>3.0.co;2-y · Cited by 331
Drach, J., Ackermann, J., Fritz, E., Krömer, E., Schuster, R., Gisslinger, H., DeSantis, M., Zojer, N., Fiegl, M., Roka, S., et al. (1998) · Blood · doi:10.1182/blood.v92.3.802 · Cited by 325
Lu, R., Nash, H. M., & Verdine, G. L. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00187-4 · Cited by 323
hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial Tumorigenesis
Esteller, M., Catasus, L., Matias-Guiu, X., Mutter, G. L., Prat, J., Baylin, S. B., & Herman, J. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65492-2 · Cited by 304
Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks
Anderson, D., Bishop, J. B., Garner, R. C., Ostrosky-Wegman, P., & Selby, P. B. (1995) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(95)00039-l · Cited by 301
Singhal, S., Vachani, A., Antin-Ozerkis, D., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2661 · Cited by 295
Rosenberg, G. A., Dencoff, J. E., Correa, N., Reiners, M., & Ford, C. C. (1996) · Neurology · doi:10.1212/wnl.46.6.1626 · Cited by 278
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma
Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H., & Hotta, T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370804 · Cited by 274
Metadata
- Authors
- 堀尾, 芳.
- Venue
- Medical Entomology and Zoology
- Publisher
- Japan Society of Medical Entomology and Zoology
- Published
- 1995-01-01
- ISSN
- 0424-7086 (ISSN-L)
- OpenAlex
- W602470663
- Cited by
- 352
- References
- 0
- Type
- dissertation
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.